Genetics of the metabolic syndrome

British Journal of Nutrition

Volumn 83, Issue SUPPL. 1, 2000, Pages

  Groop, Leif ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GLYCOGEN SYNTHASE; GLYCOPROTEIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; MELANOCORTIN; MELANOCORTIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN;

CONFERENCE PAPER; EXPERIMENTAL MODEL; FATTY ACID METABOLISM; GENETIC RISK; GENOME; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; NONHUMAN; OBESITY; RISK FACTOR;

EID: 0034127845     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0007114500000945     Document Type: Conference Paper

References (113)

1. Alberti K, Zimmet P & Consultation W (1998) Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Medicine 15, 539-553.
2. Almind K, Bjoerbaek C, Vestergaard H, Hansen T, Echwald S & Pedersen O (1993) Amino acid polymorphism of the insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342, 828-832.
3. Altsuler D, Kruglyak L & Lander E (1998) Genetic polymorphism and disease. New England Journal of Medicine 338, 1626.
4. Balkau B, Charles M & Group E (1999) Comments on the provisional report from the WHO consultation. Diabetic Medicine 16, 442-443.
5. Banerji M, Chaiken R, Gordon D, Kral J & Lebovitz H (1995) Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 44, 141-146.
6. Beck-Nielsen H & Groop L (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 94, 1714-1721.
7. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna R & Muggeo M (1998) Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 47, 1643-1649.
8. Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P & Giacobino J-P (1997) Uncoupling protein 3: a member of the mitochondrial carrier family with tissue specific expression. FEBS Letters 408, 39-42.
9. Bouchard C (1996) Genetics of body fat content. In Progress in Obesity Research 7, pp. 33-41 [H Angel, H Anderson, C Bouchard, D Lau, L Leiter and R Mendelson, editors]. London: John Libbey.
10. Bouchard C, Perusse L, Leblanc C, Tremblay A & Theriault G (1988) Inheritance of the amount and distribution of human body fat. International Journal of Obesity 12, 205-215.
11. Bouchard C, Rice T, Lemieux S, Despres J, Perusse L & Rao D (1996) Major gene for abdominal visceral fat area in the Quebec Family Study. International Journal of Obesity 20, 420-427.
12. Carey D, Nguyen T, Campbell L, Chisholm D & Kelly P (1996) Genetic influences on central abdominal fat: a twin study. International Journal of Obesity 20, 722-726.
13. Chagnon Y, Chen W, Perusse L, Chagnon M, Nadeau A, Wilkinson B & Bouchard C (1997) Linkage and association studies between the melanocortin receptor-4 and receptor-5 genes and obesity-related phenotypes in the Quebec family study. Molecular Medicine 3, 663-673.
14. Chung W, Luke A, Cooper R et al. (1999) Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. Diabetes 48, 1890-1895.
15. Clausen J, Hansen T, Bjoerbaek C, Echwald S, Urhammer S, Rasmussen S, Andersen C, Hansen L, Almind K, Winther K, Haraldsdottir J, Borch-Johnsen K & Pedersen O (1995) Insulin resistance: interactions between obesity and a common variant of the insulin receptor substrate-I. Lancet 346, 397-402.
16. Clément K, Ruiz J & Cassard-Doulcier A (1996) Additive effect of A-G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta-3-adrenergic receptor gene on weight gain in morbid obesity. International Journal of Obesity 20, 1062-1066.
17. Clément K, Vaisse C, Lahlou N et al. (1998) A mutation in the leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398-401.
18. Clément K, Vaisse C, Manning B, Basdevant A, Guy-Grand B, Ruiz J, Silver K, Shuldiner A, Froguel P & Strosberg A (1995) Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New England Journal of Medicine 333, 352-354.
19. Coleman D (1973) Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9, 294-298.
20. Coleman D (1979) Obesity genes: beneficial effects in heterozygous mice. Science 203, 663-665.
21. Comuzzie A, Hixson J, Almasy L, Mitchell B, Mahaney M, Dyer T, Stern M, MacCluer J & Blangero J (1997) A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nature Genetics 15, 273-276.
22. Consindine R, Consindine E, William C, Nyce M, Magosin S, Bauer T, Rosato E, Colberg J & Caro J (1995) Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. Journal of Clinical Investigation 95, 2986-2988.
23. Deeb S, Fajas L, Nemoto M, Laakso M, Fujimoto W & Auwerx J (1998) A Pro 12Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity and lowered body mass index. Nature Genetics 20, 284-287.
24. DeFronzo R & Ferrannini E (1991) Insulin resistance: a multifacet syndrome responsible for NIDDM obesity, hypertension dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14, 173-194.
25. Ek J, Urhammer S, Sorensen F, Anderson T, Auwerx J & Pedersen O (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferator-activated receptor gamma2 (PPARgamma2): divergent modulating effects on body mass index in obese and lean men of Caucasian origin. Diabetologia 42, 892-895.
26. Emorine L, Marullo S, Briend-Sutren M, Patey G, Tate K, Delavier-Klutchko C & Strosberg A (1989) Molecular characterization of the human beta-3-adrenergic receptor. Science 245, 1118-1121.
27. Enerbäck S, Jacobsson A, Simpson E, Guerra C, Yamashita H, Harper M-E & Kozak L (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387, 90-93.
28. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widèn E, Schalin C & Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. New England Journal of Medicine 321, 337-343.
29. Fan W, Boston B, Kesterson R, Hurby V & Cone R (1997) Role of melanocrotinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168.
30. Fernandéz-Real J, Gutierrez C, Ricart W, Casamitjana R, Fernandéz-Castanér M, Vendrell J, Richart C & Soler J (1997) The TNF-alpha gene Ncol polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. Diabetes 46, 1468-1472.
31. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico M, Oleggini M, Pedrinelli R, Brandi L & Bevilacqua S (1987) Insulin resistance in essential hypertension. New England Journal of Medicine 317, 350-357.
32. Forsblom C, Eriksson J, Ekstrand A, Teppo A-M, Taskinen M-R & Groop L (1995) Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 38, 363-369.
33. Forsblom C, Kanninen T, Lehtovirta T, Kaprio JCS & Groop L (1999) Albumin excretion is an inherited trait in families with NIDDM? Diabetologia 42, 1359-1366.
34. Fujisawa T, Ikegami H, Kawaguchi Y & Ogihara T (1998) Metaanalysis of the association of the Trp64Arg polyomorphism of the beta-3-adrenergic receptor gene with body mass index. Journal of Clinical Endocrinology and Metabolism 83, 2441-2444.
35. Gagnon J, Mauriege P, Roy S, Sjöström D, Chagnon Y, Dionne F, Oppert J-M, Perussé L, Sjöström L & Bouchard C (1996) The Trp64Arg mutation of the beta-3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec family study and Swedish obese subjects cohort. Journal of Clinical Investigation 98, 2086-2093.
36. Ghosh S, Watanabe R. Hauser E et al. (1999) Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proceedings of the National Academy of Sciences, USA 96, 2198-2203.
37. Green S, Turki J, Innis M & Liggett S (1994) Aminoterminal polymorphisms of the human beta-2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419.
38. Groop L & Ferrannini E (1993) Insulin action and substrate competition. Baillière's Clinical Endocrinology and Metabolism 7, 1007-1032.
39. Groop L & Tuomi T (1997) Non-insulin-dependent diabetes mellitus - a collision between thrifty genes and an affluent society. Annals of Medicine 29, 37-53.
40. Groop L, Kankuri M, Schalin-Jäntti C, Ekstrand A, Nikula-Ijäs P, Widèn E, Kuismanen E, Eriksson J, Franssila-Kallunki A, Saloranta C & Koskimies S (1993) Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. New England Journal of Medicine 328, 10-14.
41. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissén M, Ehrnström B-O, Forsén B, Isomaa B, Snickars B & Taskinen M-R (1996) Metabolic consequences of a family history of NIDDM (The Botnia Study). Diabetes 45, 1585-1593.
42. Haffner S, Valdez R, Hazuda H, Mitchell B, Morales P & Stern M (1992) Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 41, 715-722.
43. Haffner S, Howard G, Mayer E, Bergman R, Savage P, Rewers M, Mykkänen L, Karter A, Hamman R & Saad M (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46, 63-69.
44. Hales C & Barker D (1992) Type 2 diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35, 595-601.
45. Hanis C, Boerwinkle E, Chakraborty R el al. (1996) A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nature Genetics 13, 161-166.
46. Hästbacka J, De la Chapelle A, Mahtani M, Clines G, Reeve-Daly M, Daly M, Hamilton B, Kusumi K, Trivedi B, Weawer A, Coloma A, Lovett M, Buckler A, Kaitila I & Lander E (1994) The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 78, 1073-1087.
47. Hattersley A, Beards F, Ballantyne E, Appleton M, Harvey R & Ellard S (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics 19, 268-270.
48. Hoffstedt J. Poirier O, Thörne A, Lönnqvist F, Herrrmann S, Cambien F & Arner P (1999) Polymorphism of the human beta-3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 48, 203-205.
49. Hong Y, Rice T, Gagnon J, Després J-P, Nadeau A, Pérusse L, Bouchard C, Leon A, Skinner J, Wilmore J & Rao D (1998) Familial clustering of insulin and abdominal visceral fat: the HERITAGE family study. Journal of Clinical Endocrinology and Metabolism 83, 4239-4245.
50. Hotamisligil G, Shargill N & Spiegelman B (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-91.
51. Hotamisigil G, Arner P, Caro J, Atkinson R & Spiegelman B (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. Journal of Clinical Investigation 95, 2409-2415.
52. Jackson R, Creemers J, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague C, Hutton J & O'Rahilly S (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature Genetics 16, 303-306.
53. Kellerer M, Rett K, Renn W, Groop L & Häring H (1996) Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity and insulin sensitivity in man. Hormone and Metabolic Research 28, 737-743.
54. Klannemark M, Orho M & Groop L (1998a) No relationship between variants in the uncoupling protein 2 gene and energy expenditure. European Journal of Endocrinology 139, 217-221.
55. Klannemark M, Orho M, Langin D, Laurell H, Holm C, Reynisdottir S, Arner P & Groop L (1998b) The putative role of the hormone sensitive lipase gene in the pathogenesis of the metabolic syndrome. Diabetologia 41, 1515-1522.
56. Knudsen P, Murtomäki S, Antikainen M, Ehnholm S, Lahdenperä S, Ehnholm C & Taskinen M-R (1997) The Asn291-Ser and Ser-477-stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridemia. European Journal of Clinical Investigation 27, 928-935.
57. Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg A. Ricquier D & Emorine L (1993) Tissue distribution of beta-3-adrenergic receptor mRNA in man. Journal of Clinical Investigation 91, 344-349.
58. Krude H, Biebermann H, Luck W, Horn R, Brabant G & Grueters A (1998) Severe early-onset obesity adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genetics 19, 155-157.
59. Kylin E (1923) Studien ueber das Hypertonie-Hyperglykämie-Hyperurikämiesyndrom. Zentralblatt fuer Innere Medizin 44, 105-127.
60. Large V, Hellström I, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L & Arner P (1997) Human beta-2-adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adiipocyte beta-2-adrenoceptor function. Journal of Clinical Investigation 100, 3005-3013.
61. Lee G-H, Proenca R, Montez J, Carroll K, Darvishzadeh J, Lee J & Friedman J (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635.
62. Lehto M, Stoffel M, Groop L, Espinosa III R, LeBeau M & Bell G (1993) Assignment of the gene encoding gycogen synthase to human chromosome 19 band q13.3. Genomics 15, 460-461.
63. Lehtovirta M, Kaprio J, Forsblom C, Eriksson JJT & Groop L (2000) Insulin secretion and insulin sensitivity in monozygotic and dizygotic twins. Diabetologia (in press).
64. Lembertas A, Perusse L, Chagnon Y, Fisler J, Warden C, Purcell-Huynh D, Dionne F, Gagnon J, Nadeau A, Lusis A & Bouchard C (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on human homologous region 20q. Journal of Clinical Investigation 100, 1240-1247.
65. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J & Arner P (1995) A pathogenetic role of visceral fat beta-3-adrenoreceptors in obesity. Journal of Clinical Investigation 95, 1109-1116.
66. Lowell B, Susulic V, Hamman A, Lawitts J, Himms-Hagen J, Boyer B, Kozak L & Flier J (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740-742.
67. Maddux B, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spemcer S, Grupe A, Henzel W, Stewart T, Reaven G & Goldfine I (1995) Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373, 448-451.
68. Maffei M, Halaas J, Ravussin E, Pratley R, Lee G, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern P & Friedman J (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1, 1155-1161.
69. Mahtani MM, Widèn E, Lehto M et al. (1996) Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genetics 14, 90-94.
70. Majer M, Mott D, Mochizuki H, Rowles J, Pedersen O, Knowler W, Bogardus C & Prochazka M (1996) Association of the glycogen synthase locus 19q13 with NIDDM in Pima Indians. Diabetologia 39, 314-321.
71. Meigs J, D'Agostino RS, Wilson P, Cupples L, Nathan D & Singer D (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham offspring study. Diabetes 46, 1594-1600.
72. Melander O, Mattiasson IKM, Groop L & Hulthén L (1999) Heredity for hypertension influences intrauterine growth and the relation between foetal growth and adult blood pressure. Journal of Hypertension 17, 1557-1561.
73. Mitchell B, Blangero J, Comuzzie A, Almasy L, Shuldiner A, Silver K, Stern M, MacCluer J & Hixson J (1998) A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. Journal of Clinical Investigation 101, 584-587.
74. Mitchell B, Cole S, Comuzzie A, Almasy L, Blangero J, MacCluer J & Hixson J (1999) A quantitative trait locus influencing BMI maps to the region of beta-3-adrenergic receptor. Diabetes 48, 1863-1867.
75. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A & Fuchs Z (1985) Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. Journal of Clinical Investigation 75, 807-817.
76. Montague C, Farroqi S, Whitehead J, Soos M, Rau H, Wareham N, Sewter C, Digby J, Mohammed S. Hurst J, Cheetham C, Earley A, Barnett A, Prins J, & O'Rahilly S (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908.
77. Mykkänen L, Zaccaro D, Wagenknecht L, Robbins D, Gabriel M & Haffner S (1998) Microalbuminuria is associated with insulin resistance in nondiabetic subjects. Diabetes 47, 703-800.
78. Naggert J, Fricker L, Varlamov O, Nishina P, Roille Y, Steiner D, Carroll R, Paigen B & Leiter E (1995) Hyperproinsulinemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature Genetics 10, 135-142.
79. Neel V (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by progress? American Journal of Human Genetics 14, 352-362.
80. Norman R, Thompson D, Foroud T, Garvey W, Bennett P, Bogardus C & Ravussin E (1996) Genome-wide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. American Journal of Human Genetics 60, 166-173.
81. Ogawa Y, Masuzaki H, Isse N, Okazaki T, Mori K, Shigemoto M, Satoh N, Tamura N, Hosohoda K, Yoshimasa Y, Jingami H, Kawada T & Nakao K (1995) Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. Journal of Clinical Investigation 96, 1647-1652.
82. Ollman M, Wilson B, Yang Y, Kerns J, Chen Y, Gantz I & Barsch G (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138.
83. Orho M. Nikula-Ijäs P, Schalin-Jäntti C, Permutt M & Groop L (1995) Isolation and characterization of the human muscle glycogen synthase gene. Diabetes 44, 1099-1105.
84. Orho-Melander M, Almgren P, Kanninen T, Forsblom C & Groop L (1999) A paired sibling analysis of the Xbal polymorphism in the muscle glycogen synthase gene. Diabetologia 42, 1138-1145.
85. Pelleymounter M, Cullen M, Baker M, Hecht R, Winters D, Boone T & Collins F (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-542.
86. Pietro-Rouxel F, Manning B, Gros J & Strosberg D (1997) The biological effect of the naturally occurring Trp64-Arg mutation on human beta-3-adrenoceptor activity. European Journal of Biochemistry 247, 1174-1179.
87. Pizzuti A, Frititta L, Argiolas A, Baratta R, Goldfine I, Bozzali M, Ercolino T, Scarlato G, Iacovello L, Vigneri R, Tassi V & Trischitta V (1999) A polymorphism (K12Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48, 1881-1884.
88. Rantala A, Kauma H, Lilja M, Savolainen M, Reunanen A & Kesäniemi Y (1999) Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. Journal of Internal Medicine 245, 163-174.
89. Reaven G (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
90. Reymer P, Gagné E & Groenemeyer B (1995) A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genetics 10, 28-34.
91. Reynisdotter S. Wahrenberg H. Carlström K, Rössner S & Arner P (1994) Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta-2-adrenoceptors. Diabetologia 37, 428-435.
92. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W & Kahn C (1998) Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New England Journal of Medicine 339, 953-959.
93. Saghizadeh M, Ong J, Garvey W, Henry R & Kern P (1996) The expression of TNFalfa by human muscle. Relationship to insulin resistance. Journal of Clinical Investigation 97, 1111-1116.
94. Sakane N, Yoshida T, Umekawa T, Kondo M, Sakai Y & Takahashi T (1997) Beta-3-adrenergic receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 40, 200-204.
95. Samaras K, Spector T, Nguyen T, Baan K, Campbell L & Kelly P (1997) Independent genetic factors determine the amount and distribution of fat in women after the menopause. Journal of Clinical Endocrinology and Metabolism 82, 781-785.
96. Seldin M, Mott D, Bhat D, Petro A, Kuhn C, Kingsmore S, Bogardus C, Opara E, Feinglos M & Surwit R (1994) Glycogen synthase: a putative locus for diet-induced hyperglycemia. Journal of Clinical Investigation 94, 1-8.
97. Shihara N, Yasuda K, Moritani T, Ue H, Adachi T, Tanaka H, Tsuda K & Seino Y (1999) The association between Trp64Arg polymorphism of the beta-3-adrenergic receptor and autonomic nervous system activity. Journal of Clinical Endocrinology and Metabolism 84, 1623-1627.
98. Sipiläinen R, Uusitupa M, Heikkinen S, Rissanen A & Laakso M (1997) Polymorphism of the beta-3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 46, 77-80.
99. Stephens T, Basinski M, Bristow P, Bue-Valleskey J, Burgett S, Craft L, Hale J, Hoffmann J, Hsiung H, Kriauciunas A, MacKellar W, Rosteck Jr P, Schoner B, Smith D, Tinsley F, Zhang X-Y & Heiman M (1995) The role of neuropeptide Y in the anti-obesity action of the obese gene product. Nature 377, 530-532.
100. Storlien L, Jenkins A, Chisholm D, Pasqoe W, Kohouri S & Kraegen E (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40, 280-289.
101. Sun X, Rothenberg P, Kahn R, Backer J, Arakai E, Wilden P, Cahill D, Goldhill B, & White M (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77.
102. Tahvanainen E, Syvänne M, Frick M, Murtomäki-Repo S, Antikainen M, Kesäniemi A, Kauma H, Pasternak A, Taskinen M-R, Ehnholm C & Study L (1998) Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. Journal of Clinical Investigation 101, 956-960.
103. Tartaglia L, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards G, Campfield L, Clark F, Dees J, Muir C, Sanker S, Moriarty A, Moore K, Smutko J, Mays G, Woolf E, Monroe C & Tepper R (1996) Identification and expression cloning of a leptin receptor ob-R. Cell 83, 1263-1271.
104. Vaisse C, Clement K, Guy-Grand B & Froguel P (1998) A frameshift mutation in human MCR4 is associated with a dominant form of obesity. Nature Genetics 20, 113-114.
105. Vidal-Puig A, Solanes G, Grujic DJS & Lowell B (1997) UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochemical and Biophysical Research Communications 235, 79-82.
106. Walston J, Silver K, Bogardus C, Knowler W, Celi F, Austin S, Manning B, Strosberg D, Stern M, Raben N, Sorkin J, Roth J & Shuldiner A (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3-adrenergic receptor gene. New England Journal of Medicine 333, 343-347.
107. Walston J, Seibert M, Jen-Yen C, Cheskin L & Andersen R (1999) Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associate with traits related to obesity and insulin resistance. Diabetes 48, 2096-2098.
108. Widèn E, Ekstrand A, Saloranta C, Franssila-Kallunki A, Eriksson J, Schalin-Jäntti C & Groop L (1992) Insulin resistance in Type 2 diabetic patients with hypertriglyceridemia. Diabetologia 35, 1140-1145.
109. Widèn E, Lehto M, Kanninen T, Walston J, Shuldiner A & Groop L (1995) Association of a polymorphism in the beta-3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. New England Journal of Medicine 333, 348-351.
110. Yamada K, Ishiyama-Shigemoto S, Ichikawa F, Yuan X, Koyanagi A, Koyama W, & Nonaka K (1999) Polymorphism in the 5′-leader cistron of the beta-2-adrenergic receptor gene associated with obesity and type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 84, 1754-1757.
111. Yeo G, Farooqi I, Aminian S, Halsell D, Stanhope R & O'Rahilly S (1998) A frameshift mutation in MCR4R associated with dominantly inherited human obesity. Nature Genetics 20, 111-112.
112. Zhang Y, Proenca R, Maffei M, Baron M, Leopold L & Friedman J (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
113. Zouali H, Hani E, Philippi A, Vionnet N, Beckmann J, Demenais F & Froguel P (1997) A susceptibility locus for early-onset non-insulin-dependent (type 2) diabetes mellitus maps to chromosome 20q proximal to the phosphoenolpyruvate carboxykinase gene. Human Molecular Genetics 6, 1401-1408.